Company: NKLR
Filing Date: 2025-12-16
Form Type: 424B3
Source: 0001213900-25-121900
Chunk: 45

Company: Terra Innovatum Global N.V.
Filing Date: 2025-12-16
Form: 424B3
Chunk 45
---

executive officers have limited experience in the management of a publicly traded company. Terra Innovatum’s management team may
not successfully or effectively manage its transition to a public company that will be subject to significant regulatory oversight and
reporting obligations under federal securities laws. Their limited experience in dealing with the increasingly complex laws pertaining
to public companies could be a disadvantage in that it is likely that an increasing amount of their time may be devoted to these activities
which will result in less time being devoted to the management and growth of New Terra Innovatum. Terra Innovatum may not have adequate
personnel with the appropriate level of knowledge, experience, and training in the accounting policies, practices or internal controls
over financial reporting required of public companies in the United States. The development and implementation of the standards
and controls necessary for New Terra Innovatum to achieve the level of accounting standards required of a public company in the United States
may require costs greater than expected. It is possible that New Terra Innovatum will be required to expand its employee base and hire
additional employees to support its operations as a public company which will increase its operating costs in future periods.

<div align='center'>18</div>

Risks Relating to Compliance with Law, Government Regulation and Litigation

A pandemic, epidemic or outbreak of an infectious disease in the United States or worldwide, including the outbreak of a novel strain of coronavirus (“COVID-19”), could adversely impact our business operations and our financial results.

If a pandemic, epidemic,
or outbreak of an infectious disease, including the resurgence of COVID-19 or the outbreak of a novel strain of COVID-19, or other public
health crisis were to affect our markets, facilities or our customers, our business could be adversely affected. The global spread of
COVID-19 has disrupted certain aspects of our operations, including the ability of certain of our employees to collaborate in-person,
and may adversely impact our business operations and financial results, including our ability to execute on our business strategy and
goals. Specifically, the continued spread of COVID-19, the potential future spread of other infectious diseases and related precautionary
measures may result in delays or disruptions in our supply chain, delays in the launch or execution of certain of our customers’
projects and a decrease of our operational efficiency in the development of our systems, products, technologies and services. We continue
to take measures within our facilities to ensure the health and safety of our employees. These measures include rearranging facilities
and work schedules to follow social distancing protocols and